Database of articles cited by EMDB/PDB/SASBDB data

Keywords
Structure methods	All X-ray diffraction NMR electron microscopy small angle scattering neutron diffraction fiber diffraction powder diffraction infrared spectroscopy EPR fluorescence transfer theoretical model Hybrid
Author
Journal
IF	>30 >20 >10 >5 all

Title	HIV-1 protease mutations and inhibitor modifications monitored on a series of complexes. Structural basis for the effect of the A71V mutation on the active site
Journal, issue, pages	J. Med. Chem., Vol. 49, Page 5777-5784, Year 2006
Publish date	Apr 28, 2005 (structure data deposition date)
Authors	Skalova, T. / Dohnalek, J. / Duskova, J. / Petrokova, H. / Hradilek, M. / Soucek, M. / Konvalinka, J. / Hasek, J.
External links	J. Med. Chem. / PubMed:16970402
Methods	X-ray diffraction
Resolution	1.93 - 2.3 Å
Structure data	PDB-1zj7: Crystal structure of a complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[S-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 Method: X-RAY DIFFRACTION / Resolution: 1.93 Å PDB-1zlf: Crystal structure of a complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor Method: X-RAY DIFFRACTION / Resolution: 2.3 Å
Chemicals	ChemComp-0ZT: N-{(2S,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl}-L-phenylalanyl-L-alpha-glutamyl-L-phenylalaninamide ChemComp-HOH: WATER ChemComp-0ZR: N-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl}-L-phenylalanyl-L-glutaminyl-L-phenylalaninamide
Source	human immunodeficiency virus 1
Keywords	HYDROLASE/HYDROLASE INHIBITOR / HIV / PROTEASE / PEPTIDOMIMETIC INHIBITOR / HYDROLASE-HYDROLASE INHIBITOR COMPLEX